Palvella Therapeutics Inc (PVLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -17,434 | -13,483 | -6,708 | -2,536 | 18,691 |
| Accounts payable and accrued liabilities | 2,238 | 2,195 | 510 | 85 | -2,245 |
| Other Working Capital | -193 | 3,360 | 1,426 | 425 | -3,149 |
| Other Operating Activity | 4,549 | 2,481 | 2,067 | 924 | -27,000 |
| Operating Cash Flow | $-10,840 | $-5,447 | $-2,705 | $-1,102 | $-13,703 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 18,433 | 12,433 | 10,000 | N/A | N/A |
| Other Financing Activity | 68,656 | -129 | -108 | 0 | 5,000 |
| Financing Cash Flow | $87,089 | $12,304 | $9,892 | $N/A | $5,000 |
| Exchange Rate Effect | 3 | N/A | N/A | N/A | N/A |
| Beginning Cash Position | 7,350 | 7,350 | 7,350 | 7,350 | 16,053 |
| End Cash Position | 83,602 | 14,207 | 14,537 | 6,248 | 7,350 |
| Net Cash Flow | $76,252 | $6,857 | $7,187 | $-1,102 | $-8,703 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,840 | -5,447 | -2,705 | -1,102 | -13,703 |
| Free Cash Flow | -10,840 | -5,447 | -2,705 | -1,102 | -13,703 |